AMG:ETR
Amgen Inc
371,20 €
arrow_downward
-0,52%(-1,95) 1 d.
1. 10., 13:17:39 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre AMG…
Otvoriť
373,15 €
Vysoká
373,15 €
Nízka
369,10 €
Trh. kap.
227,88 mld.
Priem. obj.
488,00
Objem
363,00
Max. za 52 týž.
383,05 €
Min. za 52 týž.
239,20 €
Počet zamestnancov
32 tis.
Otvoriť
373,15 €
Vysoká
373,15 €
Nízka
369,10 €
Trh. kap.
227,88 mld.
Priem. obj.
488,00
Objem
363,00
Max. za 52 týž.
383,05 €
Min. za 52 týž.
239,20 €
Počet zamestnancov
32 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
AD HOC NEWS
·
pred 1 hodinou
Amgen reports Phase 3 results and Amgen stock trades at EUR 371.13
kalkine.ca
·
pred 1 dňom
Amgen (NASDAQ:AMGN) Stock: Dazodalibep's Phase 3 Win Targets a Disease With No Approved Medicines
TradingKey
·
pred 2 dňami
Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Informácie o subjekte Amgen Inc
Generálny riaditeľRobert A. Bradway
Zamestnanci31,5 tis.
Dátum založenia1980
Hlavné sídloThousand Oaks, Kalifornia, Spojené štáty americké
Odvetvie-
Webamgen.com